Survivin can be deregulated in cancer by several mechanisms, such as amplification of the Survivin locus on chromosome 17q25(15), demethylation of Survivin exons [9], increased promoter activity [10], and the upstream signaling in the PI3K/AKT or MAPK pathways [11]. The gene discussed is AKT1; the disease is cancer.